expression of LMX1B, as well as other cooperating and compensating signaling pathways, underlie both the constraints on abnormalities typically observed in Nail-Patella syndrome and the heterogeneity of clinical presentation observed from patient to patient. 4 LMX1B mutations account for 95% of all Nail-Patella syndrome cases, 2 leaving some cases unexplained even after comprehensive LMX1B mutation profiling.
Here, we present the exome sequencing findings for four generations of a family with nail dysplasia and some features of Nail-Patella syndrome. Prior to referral for exome sequencing, the proband of this family underwent workup for Nail-Patella syndrome; however, her pelvic radiograph results were negative for iliac horns, her patellas were not small, and test results were negative for LMX1B mutation. Although many of the classic findings for Nail-Patella syndrome were not observed, given the similarity of the nail dysplasia observed in this family to that observed in Nail-Patella syndrome and the co-occurrence of joint laxity, the case was referred for exome sequencing for a suspected Nail-Patella-like disorder or other connective-tissue disorder. Exome sequencing, bioinformatic analysis, and application of standard inheritancebased, population-based, and coding impact filters resulted in the conclusion that a loss-of-function mutation in WIF1, a WNT signaling regulator involved in mesoderm segmentation, 5 was the suspected novel cause of the Nail-Patella-like disorder observed in this family.
MATERIALS AND METHODS

Study consent
Study participants provided written informed consent and the protocol was approved by the institutional review board of Scripps.
Whole-exome sequencing, variant calling, and filtration
DNA was extracted from freshly drawn blood and wholeexome sequencing (WES) was pursued utilizing Agilent SureSelect exome hybridization followed by barcoding and sequencing of paired 100-bp reads on an Illumina HiSeq2500 instrument. Read mapping, variant calling, and quality filtration were performed using a BWA-GATK best-practices variant quality score recalibration approach. Mean coverage of 86× per individual was achieved with 98.1% of the target exome covered by >10 reads. Variant annotation was performed using the SG-ADVISER system. 4 A series of filters was applied to derive a set of candidate disease-causative variants ( Table 2) : (i) population-based filtration, because of the rarity of this condition, removed variants present at >0.2% allele frequency in the Exome Aggregation Consortium, 6 1000 Genomes, 7 the NHLBI Exome Sequencing Project, 8 or Scripps Wellderly populations; 9 (ii) functional impact-based filtration to remove variants that are not nonsynonymous, frameshift, in-frame, nonsense, or do not affect canonical splice-site donor/acceptor sites; and (iii) inheritance-based filters to remove variants that do not segregate in the family in a manner consistent with autosomal dominant inheritance.
RESULTS
Phenotype
The proband was a 45-year-old woman presenting with dysplastic ridged nails, and joint laxity. She had a history of multiple fractures with minimal trauma; a torn anterior cruciate ligament; subluxations of the left shoulder, knee, and temporomandibular joints; spondylolisthesis; and arthritis. Prior to referral for exome sequencing, she was evaluated for Nail-Patella syndrome with radiographs of the knees and pelvis, which documented patellas of normal size and no iliac horns. Genetic testing for pathogenic deletions, duplications, and mutations in LMX1B was negative (Fulgent Diagnostics).
Nail dysplasia and joint laxity co-occur in a variety of disorders, all of which are associated with additional severe findings. A search for disorders with combined nail dysplasia (human phenotype ontology identifier HP:0002164) and joint laxity (HP:0001388) via the Phenomizer tool 10 returned possible diagnoses that were severe syndromic disorders (Meier-Gorlin syndrome, Costello syndrome, chromosome 2q32-q33 deletion syndrome, Weaver syndrome, Coffin-Lowry syndrome, craniofrontonasal syndrome, and focal dermal hypoplasia), severe bone development disorders (metaphyseal chondrodysplasia and cranioectodermal dysplasia), or Nail-Patella syndrome. Therefore, although many of the classic findings for Nail-Patella syndrome were not observed, we concluded that the phenotype observed in the proband was nail dysplasia with some features of Nail-Patella syndrome, or what we refer to as a Nail-Patella-like disorder.
Family history included four generations of 14 total individuals with nail dysplasia and a variety of connective-tissue concerns (Table 1, Figure 1, Supplementary Figures S2 and S3 online). All affected family members belonged to the maternal lineage of the proband, including the mother, grandmother, and maternal aunts, uncles, cousins, brother, and niece of the proband (see pedigree in Figure 2 ); there were two instances of male-to-male transmission supporting autosomal dominant inheritance in the maternal lineage. To identify candidate genetic variants underlying the Nail-Patella-like disorder observed in four generations of this family, WES was pursued for five individuals in the family, the mother-father-proband trio and two cousins (the most distantly related family members available for sequencing). Follow-up genotyping of candidate variants was performed in these individuals plus an additional five members of the family. (Figure 1b) . Variants discovered by WES were annotated by SG-ADVISER. 4 Nonsynonymous, inframe, frameshift, nonsense, and consensus splice site variants, at a threshold population allele frequency of <0.2%, were filtered under an autosomal dominant model of inheritance. This allele frequency threshold is 100-fold higher than the incidence of Nail-Patella syndrome (1 in 50,000). Twelve candidate causative variants were retained after filtration ( Table 2) . Follow-up genotyping, via Sanger sequencing, for the 12 candidate variants was performed in the above mentioned individuals plus three affected children (ID41K6, ID41K7, ID41K8), an affected maternal uncle (ID41K9), and an affected maternal aunt (ID41K10) of the proband (Figure 1b) . This process ultimately resulted in the retention of three candidate variants: KRT74 p.R379L, RDH16 p.R153G, and WIF1 p.W15* (shown in boldface in Table 2 ).
DISCUSSION
Relaxed allele frequency-based filtration of coding variants inherited in an autosomal dominant fashion in the study family resulted in three candidate genes for the observed Nail-Patellalike disorder: KRT74, RDH16, and WIF1. It should be noted that the underlying assumption leading to the identification of these three candidate variants was that the disorder is driven by a coding mutation captured by exome sequencing, and that the Nail-Patella-like disorder observed in this family is rare. No assumptions regarding the specific phenotype were included in this variant prioritization approach-i.e., variants underlying other known causes of nail dysplasia or other connective-tissue disorders would have been captured by our analysis approach. Given our initial assumptions, further filtration of the candidate variants by allele frequency under the assumption of complete penetrance, and prioritization based on biological relevance of the candidate genes, resulted in the conclusion that mutation of WIF1 was the suspected cause of Nail-Patella-like disorder in this family.
The candidate variant in KRT74 can probably be removed from consideration on the basis of phenotype as well as allele frequency. KRT74 is an epithelial keratin known to cause autosomal dominant woolly hair and autosomal recessive ectodermal dysplasia. 11 The family in this report had normal hair, teeth, skin, and sweat glands. Moreover, this particular variant in KRT74 (rs143748352) has been observed at 0.047% allele frequency in Europeans, 6 which is an approximately 25-fold excess of the incidence of Nail-Patella syndrome. Therefore, under the assumption of near-complete penetrance, which was appropriate given the pattern of inheritance observed in this family, the variant in KRT74 was unlikely to be a cause of the observed Nail-Patella-like disorder. However, we could not fully exclude the possibility that the variant contributed to a portion of the phenotype observed in this family.
The candidate variant in RDH16 cannot definitively be eliminated from consideration due to allele frequency, but its known function does not appear to fit the observed phenotype. The variant in RDH16 (rs372580365) has been observed at 0.006% allele frequency in Europeans, 6 which is slightly (3×) greater than the incidence of Nail-Patella syndrome-an excess that would be amplified further given that 95% of cases are already explained by mutation in LMX1B mutation (60× greater). Moreover, RDH16 is a liver-specific retinol dehydrogenase that plays no known role in connective-tissue biology. Finally, RDH16 knockout mice have no significant abnormalities. 12 However, the variant in WIF1 is a strong candidate as the cause of a novel Nail-Patella-like disorder. The nonsense variant (WIF1 p.W15*) observed in this gene has not previously been observed in more than 100,000 genomes. 6 Therefore, the frequency of this variant is consistent with a fully penetrant cause of the observed disorder. Moreover, WIF1 is a secreted antagonist of WNT signaling, expressed predominantly at the superficial layer of epiphyseal and articular cartilage, and it is known to promote chondrogenesis. 13 In mouse models of arthritis, loss of WIF1 aggravates cartilage damage. 14 The observed nonsense mutation in WIF1 is expected to result in the complete loss of the N-terminal signal peptide of WIF1 (amino acids 1-28) and thus inhibit its secretion into the extracellular matrix, where it inhibits WNT factors. Therefore, loss of WIF1 function would be expected to lead to joint cartilage abnormalities. Moreover, WIF1 functions within the same molecular signaling network as LMX1B-a WNT-responsive transcription factor. 15 The WNT pathway controls a variety of embryonic development processes. The specificity of WNT signaling is achieved through a variety of WNT ligands, each of which is subject to highly organized temporal and spatially restricted patterns of expression to coordinate embryonic development. 16 A complex, and not fully understood, interplay between WNT and other signaling cascades is known to mediate joint development. 17 Similarly, WNT signaling is known to play a central role in nail development, 18 although the precise molecular mechanisms have not been well described. It is thought that the role of LMX1B as both a necessary and sufficient mediator of WNT signaling to specify dorsal limb patterning, specifically through induction by the WNT ligand WNT7A, underlies the primary abnormalities observed in Nail-Patella syndrome. 15 However, LMX1B is also involved in a variety of other complex WNT-dependent processes, in which LMX1B function may be compensated for by other factors, potentially leading to the phenotypic heterogeneity observed across Nail-Patella syndrome cases. 19 Similarly, WIF1 interacts with a variety of WNT ligands, including WNT7A, and thus participates in an overlapping set of WNT signaling functions as LMX1B. 20 However, the details of the role of WIF1 in embryonic and other developmental processes have not been well described.
Further study of additional WIF1-positive cases would help elucidate the role of WIF1 mutation in Nail-Patella-like disorder and the role of WNT signaling in nail and joint development. The phenotype in this family evolves over time. The majority of affected individuals have abnormal nails at birth but do not manifest other features until they become competitively active during adolescence. Multiple joint dislocations and arthritis are most troublesome. Two older members of the family have developed renal issues and one has glaucoma. It is unclear whether these features are related to the WIF1 mutation or are unrelated. Longitudinal follow-up of family members is clearly warranted. The complete phenotypic spectrum due to loss of WIF1 function may be clarified if more families are reported.
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